{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:17:38Z","timestamp":1783441058097,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fonds de recherche du Qu\u00e9bec-Sant\u00e9 (FRQS) Junior 2 Research scholar","award":["347345"],"award-info":[{"award-number":["347345"]}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","award":["https:\/\/doi.org\/10.69777\/283708"],"award-info":[{"award-number":["https:\/\/doi.org\/10.69777\/283708"]}],"id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004889","name":"Fondation du CHU de Qu\u00e9bec","doi-asserted-by":"crossref","award":["Chaire de recherche hospitali\u00e8re Diab\u00e8te et Maladies Endocriniennes"],"award-info":[{"award-number":["Chaire de recherche hospitali\u00e8re Diab\u00e8te et Maladies Endocriniennes"]}],"id":[{"id":"10.13039\/501100004889","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>: Amino acids (AAs), tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines (ACs) can reflect energetic metabolism. Metabolic dysfunction-associated steatotic liver (MASLD) has been associated with the modification of plasma AAs, ACs and TCA cycle intermediates\u2019 profiles, but the changes in advanced fibrosis without type 2 diabetes (T2D) are not well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      The objective of this pilot study was to describe the targeted plasma metabolomic profile in individuals with advanced fibrosis to test research hypotheses concerning hepatic energy metabolism. Methods: We compared plasma fasting concentrations of 21 AAs, 11 organic acids (including ketone bodies and TCA cycle intermediates) and 14 ACs between individuals with advanced fibrosis stages (F3-F4\/4) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) and individuals with no advanced fibrosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910), all without T2D and with similar clinical characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age (IQR) (51 [43\u201367] vs. 57 [43\u201366] years), sex (30 vs. 50% men) and BMI (35 [28\u201337] vs. 37 [32\u201339] kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) were comparable between groups. The advanced fibrosis (AF) group presented higher plasma tyrosine (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), \u03b1-ketoglutarate (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), and a lower level of medium-chain ACs C8 and C10 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). The glutamate-glycine-serine (GSG) index, which combines AAs involved in glutathione metabolism, was higher in the AF group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, our results suggest impaired AAs catabolism and mitochondrial dysfunction. While the limited sample size and study design preclude causal inferences, these findings highlight potential metabolic signatures of advanced fibrosis in MASLD. They also underscore the need for larger, longitudinal studies to clarify their origin, significance, and clinical implications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11306-026-02437-1","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:52:01Z","timestamp":1778161921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D)."],"prefix":"10.1007","volume":"22","author":[{"given":"Marion","family":"Pradeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-Catherine","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Robillard Frayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ferland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Carreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2437_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00726-011-1088-7","volume":"43","author":"MM Adeva","year":"2012","unstructured":"Adeva, M. M., Calvi\u00f1o, J., Souto, G., & Donapetry, C. (2012). Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids, 43, 171\u2013181.","journal-title":"Amino Acids"},{"key":"2437_CR2","doi-asserted-by":"crossref","first-page":"e0154601","DOI":"10.1371\/journal.pone.0154601","volume":"11","author":"G Aragon\u00e8s","year":"2016","unstructured":"Aragon\u00e8s, G., Auguet, T., Berlanga, A., Guiu-Jurado, E., Martinez, S., Armengol, S., Sabench, F., Ras, R., Hernandez, M., Aguilar, C., Colom, J., Sirvent, J. J., Del Castillo, D., & Richart, C. (2016). Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. PLOS ONE, 11, e0154601.","journal-title":"PLOS ONE"},{"key":"2437_CR3","doi-asserted-by":"crossref","first-page":"a040584","DOI":"10.1101\/cshperspect.a040584","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel, N. S. (2021). Amino Acid Metabolism. Cold Spring Harbor Perspectives in Biology, 13, a040584.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"2437_CR4","doi-asserted-by":"crossref","unstructured":"David, C., Deschenes, S., Ichkhan, G., Daneault, C., Robillard Frayne, I., Bouchard, B., Forest, A., Shi, Y. F., Higgins, M. E., Sirois, M. G., Tardif, J. C., Mericskay, M., Piquereau, J., & Ruiz, M. (2025). Sex-specific modulation of cardiac fibrosis and lipid metabolism by B-vitamins in heart failure with reduced ejection fraction in mice. Am J Physiol Heart Circ Physiol 329, H69-H86.","DOI":"10.1152\/ajpheart.00841.2024"},{"key":"2437_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","volume":"10","author":"K Du","year":"2020","unstructured":"Du, K., Chitneni, S. K., Suzuki, A., Wang, Y., Henao, R., Hyun, J., Premont, R. T., Naggie, S., Moylan, C. A., Bashir, M. R., Abdelmalek, M. F., & Diehl, A. M. (2020). Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. Cellular and Molecular Gastroenterology and Hepatology, 10, 1\u201321.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"2437_CR6","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","volume":"154","author":"K Du","year":"2018","unstructured":"Du, K., Hyun, J., Premont, R. T., Choi, S. S., Michelotti, G. A., Swiderska-Syn, M., Dalton, G. D., Thelen, E., Rizi, B. S., Jung, Y., & Diehl, A. M. (2018). Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Gastroenterology, 154, 1465\u20131479e13.","journal-title":"Gastroenterology"},{"key":"2437_CR7","doi-asserted-by":"crossref","unstructured":"Fletcher, J. A., Deja, S., Satapati, S., Fu, X., Burgess, S. C., & Browning, J. D. (2019). Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI Insight, 5, e127737.","DOI":"10.1172\/jci.insight.127737"},{"key":"2437_CR8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/jcm7120513","volume":"7","author":"JL Flores-Guerrero","year":"2018","unstructured":"Flores-Guerrero, J. L., Ost\u00e9, M. C. J., Kieneker, L. M., Gruppen, E. G., Wolak-Dinsmore, J., Otvos, J. D., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2018). Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study. Journal of Clinical Medicine, 7, 513.","journal-title":"Journal of Clinical Medicine"},{"key":"2437_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","volume":"78","author":"B Fromenty","year":"2023","unstructured":"Fromenty, B., & Roden, M. (2023). Mitochondrial alterations in fatty liver diseases. Journal Of Hepatology, 78, 415\u2013429.","journal-title":"Journal Of Hepatology"},{"key":"2437_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini, M., Carli, F., Rosso, C., Buzzigoli, E., Marietti, M., Della Latta, V., Ciociaro, D., Abate, M. L., Gambino, R., Cassader, M., Bugianesi, E., & Gastaldelli, A. (2018). Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Hepatology, 67, 145\u2013158.","journal-title":"Hepatology"},{"key":"2437_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/metabo12050440","volume":"12","author":"\u00c9 Gobeil","year":"2022","unstructured":"Gobeil, \u00c9., Maltais-Payette, I., Taba, N., Bri\u00e8re, F., Ghodsian, N., Abner, E., Bourgault, J., Gagnon, E., Manikpurage, H. D., Couture, C., Mitchell, P. L., Mathieu, P., Julien, F., Corbeil, J., Vohl, M. C., Th\u00e9riault, S., Esko, T., Tchernof, A., & Arsenault, B. J. (2022). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites, 12, 440.","journal-title":"Metabolites"},{"key":"2437_CR12","doi-asserted-by":"crossref","unstructured":"Houten, S. M., Wanders, R. J., & Ranea-Robles, P. (2020). Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism. Biochimica et biophysica acta. Molecular basis of disease 1866.","DOI":"10.1016\/j.bbadis.2020.165720"},{"key":"2437_CR13","first-page":"105346","volume":"31","author":"V Isakov","year":"2025","unstructured":"Isakov, V. (2025). Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass. World Journal Of Gastroenterology, 31, 105346.","journal-title":"World Journal Of Gastroenterology"},{"key":"2437_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2016.01.026","volume":"172","author":"R Jin","year":"2016","unstructured":"Jin, R., Banton, S., Tran, V. T., Konomi, J. V., Li, S., Jones, D. P., & Vos, M. B. (2016). Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease\u2014An Untargeted, High Resolution Metabolomics Study. The Journal of Pediatrics, 172, 14\u201319e5.","journal-title":"The Journal of Pediatrics"},{"key":"2437_CR42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan, S.C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A.J., Hanson, R.W. and Milburn, M. (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism, 60, 404-13.","journal-title":"Metabolism"},{"key":"2437_CR15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","volume":"47","author":"AD Lake","year":"2015","unstructured":"Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D. G., Reily, M. D., Lehman-McKeeman, L. D., Vaillancourt, R. R., & Cherrington, N. J. (2015). Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. Amino Acids, 47, 603\u2013615.","journal-title":"Amino Acids"},{"key":"2437_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2012.11.008","volume":"55","author":"B Lauzier","year":"2013","unstructured":"Lauzier, B., Vaillant, F., Merlen, C., Gelinas, R., Bouchard, B., Rivard, M. E., Labarthe, F., Dolinsky, V. W., Dyck, J. R., Allen, B. G., Chatham, J. C., & Rosiers, D., C (2013). Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway. Journal Of Molecular And Cellular Cardiology, 55, 92\u2013100.","journal-title":"Journal Of Molecular And Cellular Cardiology"},{"key":"2437_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/metabo9020036","volume":"9","author":"S Li","year":"2019","unstructured":"Li, S., Gao, D., & Jiang, Y. (2019). Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma. Metabolites, 9, 36.","journal-title":"Metabolites"},{"key":"2437_CR18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","volume":"18","author":"M Masoodi","year":"2021","unstructured":"Masoodi, M., Gastaldelli, A., Hy\u00f6tyl\u00e4inen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., Mato, J. M., Dufour, J. F., & Ore\u0161i\u010d, M. (2021). Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nature Reviews Gastroenterology & Hepatology, 18, 835\u2013856.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"2437_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1872-034X.2009.00614.x","volume":"40","author":"K Michitaka","year":"2010","unstructured":"Michitaka, K., Hiraoka, A., Kume, M., Uehara, T., Hidaka, S., Ninomiya, T., Hasebe, A., Miyamoto, Y., Ichiryu, M., Tanihira, T., Nakahara, H., Ochi, H., Tanabe, A., Uesugi, K., Tokumoto, Y., Mashiba, T., Abe, M., Hiasa, Y., Matsuura, B., & Onji, M. (2010). Amino acid imbalance in patients with chronic liver diseases. Hepatology Research, 40, 393\u2013398.","journal-title":"Hepatology Research"},{"key":"2437_CR20","doi-asserted-by":"crossref","unstructured":"Miwa Kawanaka, M., Nishino, K., Oka, T., Urata, N., Nakamura, J., Suehiro, M., Kawamoto, H., Chiba, Y., & Yamada, G. (2015). Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease. Hepatic Medicine: Evidence and Research, 7, 29.","DOI":"10.2147\/HMER.S79100"},{"key":"2437_CR21","doi-asserted-by":"crossref","first-page":"946474","DOI":"10.3389\/fphys.2022.946474","volume":"13","author":"RGR Mooli","year":"2022","unstructured":"Mooli, R. G. R., & Ramakrishnan, S. K. (2022). Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. Frontiers In Physiology, 13, 946474.","journal-title":"Frontiers In Physiology"},{"key":"2437_CR22","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1152\/ajpendo.00336.2023","volume":"326","author":"MP Moore","year":"2024","unstructured":"Moore, M. P., Shryack, G., Alessi, I., Wieschhaus, N., Meers, G. M., Johnson, S. A., Wheeler, A. A., Ibdah, J. A., Parks, E. J., & Rector, R. S. (2024). Relationship between serum beta-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD. American Journal Of Physiology. Endocrinology And Metabolism, 326, E493\u2013E502.","journal-title":"American Journal Of Physiology. Endocrinology And Metabolism"},{"key":"2437_CR23","doi-asserted-by":"crossref","unstructured":"Morgan, M. Y., Marshall, A. W., Milsom, J. P., & Sherlock, S. (1982). Plasma amino-acid patterns in liver disease. Gut, 23, 362-70.","DOI":"10.1136\/gut.23.5.362"},{"key":"2437_CR24","doi-asserted-by":"crossref","first-page":"30409","DOI":"10.1074\/jbc.R200006200","volume":"277","author":"OE Owen","year":"2002","unstructured":"Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002). The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function. Journal of Biological Chemistry, 277, 30409\u201330412.","journal-title":"Journal of Biological Chemistry"},{"key":"2437_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/apt.18451","volume":"61","author":"S Owrangi","year":"2025","unstructured":"Owrangi, S., Paik, J. M., Golabi, P., De Avila, L., Hashida, R., Nader, A., Paik, A., Henry, L., & Younossi, Z. M. (2025). Meta-Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction\u2010Associated Steatotic Liver Disease. Alimentary Pharmacology & Therapeutics, 61, 433\u2013443.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"2437_CR26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jchromb.2013.05.028","volume":"932","author":"M Peng","year":"2013","unstructured":"Peng, M., Liu, L., Jiang, M., Liang, C., Zhao, X., Cai, Y., Sheng, H., Ou, Z., & Luo, H. (2013). Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS\/MS without derivatization. Journal Of Chromatography. B, Analytical Technologies In The Biomedical And Life Sciences, 932, 12\u201318.","journal-title":"Journal Of Chromatography. B, Analytical Technologies In The Biomedical And Life Sciences"},{"key":"2437_CR27","doi-asserted-by":"crossref","unstructured":"Post, A., Garcia, E., Van Den Berg, E. H., Flores-Guerrero, J. L., Gruppen, E. G., Groothof, D., Westenbrink, B. D., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021). Nonalcoholic fatty liver disease, circulating ketone bodies and all\u2010cause mortality in a general population\u2010based cohort. European Journal of Clinical Investigation, 51, e13627.","DOI":"10.1111\/eci.13627"},{"key":"2437_CR28","doi-asserted-by":"crossref","unstructured":"Pradeau, M., Beaulieu, S., Paquet, V., Trottier, J., Verreault, M., Ferland, S., Barbier, O., & Carreau, A. M. (2025). Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis. Am J Physiol Endocrinol Metab.","DOI":"10.1152\/ajpendo.00346.2024"},{"key":"2437_CR29","doi-asserted-by":"crossref","unstructured":"Ruiz, M., Cuillerier, A., Daneault, C., Deschenes, S., Frayne, I. R., Bouchard, B., Forest, A., Legault, J. T., Consortium, L., Vaz, F. M., Rioux, J. D., Burelle, Y., & Des Rosiers, C. (2019). Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder. JCI Insight, 4, e123231.","DOI":"10.1172\/jci.insight.123231"},{"key":"2437_CR30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/jcm9020314","volume":"9","author":"Y Sandlers","year":"2020","unstructured":"Sandlers, Y., Shah, R. R., Pearce, R. W., Dasarathy, J., Mccullough, A. J., & Dasarathy, S. (2020). Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine, 9, 314.","journal-title":"Journal of Clinical Medicine"},{"key":"2437_CR31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/hepr.13651","volume":"51","author":"S Sato","year":"2021","unstructured":"Sato, S., Amano, N., Sato, S., Kita, Y., Ikeda, Y., Kabemura, D., Murata, A., Yatagai, N., Tsuzura, H., Shimada, Y., & Genda, T. (2021). Elevated serum tyrosine concentration is associated with a poor prognosis among patients with liver cirrhosis. Hepatology Research, 51, 786\u2013795.","journal-title":"Hepatology Research"},{"key":"2437_CR32","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1152\/ajpendo.00503.2014","volume":"309","author":"MG Schooneman","year":"2015","unstructured":"Schooneman, M. G., Ten Have, G. A., van Vlies, N., Houten, S. M., Deutz, N. E., & Soeters, M. R. (2015). Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism. American Journal Of Physiology. Endocrinology And Metabolism, 309, E256\u2013E264.","journal-title":"American Journal Of Physiology. Endocrinology And Metabolism"},{"key":"2437_CR33","doi-asserted-by":"crossref","first-page":"101134","DOI":"10.1016\/j.molmet.2020.101134","volume":"50","author":"M Shum","year":"2021","unstructured":"Shum, M., Ngo, J., Shirihai, O. S., & Liesa, M. (2021). Mitochondrial oxidative function in NAFLD: Friend or foe? Mol Metab, 50, 101134.","journal-title":"Mol Metab"},{"key":"2437_CR34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","volume":"14","author":"E Sunny","year":"2011","unstructured":"Sunny, E., Nishanth, Parks, J., Elizabeth, Browning, D., Jeffrey and, & Burgess, C., Shawn (2011). Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease. Cell Metabolism, 14, 804\u2013810.","journal-title":"Cell Metabolism"},{"key":"2437_CR35","doi-asserted-by":"crossref","unstructured":"Tessari, P., Vettore, M., Millioni, R., Puricelli, L., & Orlando, R. (2010). Effect of liver cirrhosis on phenylalanine and tyrosine metabolism. Current opinion in clinical nutrition and metabolic care 13.","DOI":"10.1097\/MCO.0b013e32833383af"},{"key":"2437_CR36","doi-asserted-by":"crossref","first-page":"H991","DOI":"10.1152\/ajpheart.00789.2015","volume":"311","author":"F Vaillant","year":"2016","unstructured":"Vaillant, F., Lauzier, B., Ruiz, M., Shi, Y., Lachance, D., Rivard, M. E., Bolduc, V., Thorin, E., Tardif, J. C., & Rosiers, D., C (2016). Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia. American Journal Of Physiology Heart And Circulatory Physiology, 311, H991\u2013H1003.","journal-title":"American Journal Of Physiology Heart And Circulatory Physiology"},{"key":"2437_CR37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/nu11030705","volume":"11","author":"E Van Den Berg","year":"2019","unstructured":"Van Den Berg, E., Flores-Guerrero, J., Gruppen, E., De Borst, M., Wolak-Dinsmore, J., Connelly, M., Bakker, S., & Dullaart, R. (2019). Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids. Nutrients, 11, 705.","journal-title":"Nutrients"},{"key":"2437_CR38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., O\u2019Donnell, C. J., Carr, S. A., Mootha, V. K., Florez, J. C., Souza, A., Melander, O., Clish, C. B., & Gerszten, R. E. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17, 448\u2013453.","journal-title":"Nature Medicine"},{"key":"2437_CR39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/dc12-0895","volume":"36","author":"P W\u00fcrtz","year":"2013","unstructured":"W\u00fcrtz, P., Soininen, P., Kangas, A. J., R\u00f6nnemaa, T., Lehtim\u00e4ki, T., K\u00e4h\u00f6nen, M., Viikari, J. S., Raitakari, O. T., & Ala-Korpela, M. (2013). Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults. Diabetes Care, 36, 648\u2013655.","journal-title":"Diabetes Care"},{"key":"2437_CR40","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023). The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology, 77, 1335\u20131347.","journal-title":"Hepatology"},{"key":"2437_CR41","doi-asserted-by":"crossref","unstructured":"Zhao, S., Feng, X. F., Huang, T., Luo, H. H., Chen, J. X., Zeng, J., Gu, M., Li, J., Sun, X. Y., Sun, D., Yang, X., Fang, Z. Z., & Cao, Y. F. (2020). The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus. Frontiers in Endocrinology 11.","DOI":"10.3389\/fendo.2020.00212"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02437-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02437-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:18:51Z","timestamp":1783437531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02437-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02437-1","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"67"}}